Home
Centre for Cancer Biomarkers CCBIO

News archive for Centre for Cancer Biomarkers CCBIO

Bakterier som klamydia kan endre celler og føre til kreft. Det kom frem under Centre for Cancer Biomarkers (CCBIO) sjette årlige symposium på Solstrand.
May and Solstrand showed off with blue skies and warm sunshine when CCBIO hosted the Liquid Biopsy Symposium May 22nd, a satellite symposium to the 6th CCBIO Annual Symposium 2018.
CCBIO PI Anne Christine Johannessen recently returned from a site visit in Sudan to follow up on a longstanding collaboration on oral cancer between Bergen and Khartoum. We asked her to tell us a little about the collaboration.
A research team led by James Lorens at the Department of Biomedicine and CCBIO used new technology to determine how breast tissue changes with age may contribute to breast cancer risk. The research is published in Cell Reports, with a commentary on Eureka Alert.
Maria Paula Ramnefjell defended April 10th 2018 her doctoral thesis "Prognostic biomarkers and clinico-pathologic characteristics in non-small cell lung cancer. A study with special focus on tumor-vascular interactions" at the University of Bergen.
The CCBIO Director Lars A. Akslen was recently awarded as Honorary Member of the Norwegian Society of Pathology (DNP). Akslen has former been chairman of the association during two periods, 2008-2012.
This year, Cancer Crosslink was organized for the 10th time, and top-notch international speakers attended the meeting entitled “Precision Treatment: Exploiting Recent Advances – Fast and Furious?”. CCBIO postdoc and gynecologist Liv Cecilie Vestrheim Thomsen chaired the meeting together with Christian Kersten, oncologist at Center for Cancer Treatment, Sørlandet Hospital, Kristiansand.
Congratulations to CCBIO dental student Martha Rolland Jacobsen for the research dissemination prize at the research fair of the Medical Faculty’s recent Clinical Dentistry Week! Martha presented her research work, which is part of a larger research project that aims to combine the expression of 13 biomarkers known to play a role in the progression of OSCC, in order to develop a molecular... Read more
The Centre for Cancer Biomarkers hosted a two-day seminar in scientific writing December 13th and 14th, and the massive interest proves that this is an issue both students and researchers feel the need to learn more about.
A new imaging center on campus with state-of-the-art imaging equipment will strengthen research activities. Three research projects have received funding to be integrated with the novel Medical Imaging and Visualisation Centre.
Mari Kyllesø Halle defended her thesis "Molecular alterations suggesting new treatment strategies in uterine carcinomas" at the University of Bergen November 10th 2017.
How do we achieve a real dialogue between Science and Society? What are scientists' responsibilities in this regard? These questions were discussed at a Round Table event 26 October 2017 at the "FEBS3+" conference in Barcelona, gathering biochemists and life scientists from France, Portugal and Spain.
The Norwegian Cancer Society has recently announced their 2017-funding. The University of Bergen and Haukeland University Hospital receive 54,7 million NOK, of which 23,2 million go to CCBIO projects.
Kristi Krüger defended November 8th her dissertation “Markers of angiogenesis and the basal-like phenotype of breast cancer”. The study has given increased knowledge of the aggressive basaloid type of breast cancer.
Postdoc in the Bergen Gynecologic Cancer Research Group, Ingvild Løberg Tangen, was awarded with the best oral presentation prize at the ESGO (European Society of Gynaecological Oncology) congress for the presentation : “Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients”.
Marit Valla defended October 12th 2017 her PhD dissertation "Molecular subtypes of breast cancer: incidence and prognosis". This was a collaboration project between the Centre for Cancer Biomarkers (CCBIO), University of Bergen (UiB), and the Department of Public Health and Nursing, the Norwegian University of Science and Technology (NTNU).
CCBIO had two representatives presenting their research at the 9th World Congress of Melanoma in Brisbane, Australia, October 18-21, 2017.
UiB/CCBIO's Bergen Oral Cancer Research Group and Experimental Pathology Research Group received in 2016 3 million NOK in funding from SIU through the Eurasia program, to a collaboration project for education and research in oral pathology between Norway, Moldova, Belarus and Armenia. The project started off with a workshop in Bergen in 2016, and the Bergen researchers and educators have... Read more

Pages